Utah Medical Products Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -10.3% | +5.3% | +16.4% | -0.4% | +1.3% | +18.1% | +5.3% | -0.3% | +5.4% | -33.4% | -0.9% | |
| – | -6.2% | -10.0% | -2.1% | +6.6% | +132.8% | +4.8% | +1.0% | -2.8% | -10.1% | -55.3% | +5.7% | |
| – | +17.6% | +5.7% | +40.2% | -50.4% | +76.6% | +41.6% | +3.8% | +10.2% | +23.0% | +13.8% | +45.7% | |
| – | – | – | – | – | – | – | +0.0% | -232.8% | – | – | – | |
| – | -134.2% | – | – | -165.9% | – | – | -150.5% | – | – | – | – | |
| – | -78.3% | +1,242.3% | -51.6% | -74.8% | +5,258.2% | -96.0% | -35.8% | +48.2% | -21.9% | -63.2% | +57.9% | |
| – | -78.3% | +1,242.3% | -51.6% | – | -4,133.7% | -96.0% | -35.8% | +48.2% | -21.9% | -67.4% | +78.4% | |
| – | +2.2% | +1.8% | -24.5% | +36.2% | +2.1% | +0.1% | +178.5% | -72.4% | +35.4% | -0.5% | -6.5% | |
| – | -35.3% | +317.3% | +0.0% | -57.7% | -67.0% | +1,652.8% | +0.0% | -64.2% | +0.0% | +700.3% | -58.2% | |
| – | +18.4% | – | – | – | – | – | – | – | – | – | – | |
| – | +7.6% | -28.7% | -58.2% | +80.1% | -11.5% | +153.9% | +1.6% | -49.7% | -24.1% | +472.3% | -48.2% | |
| – | -17.9% | -24.6% | +349.9% | -17.2% | -174.1% | – | +6.6% | +50.0% | +26.6% | -155.5% | – | |
| – | -4.9% | -17.2% | +36.4% | +7.3% | -127.3% | – | +7.1% | -1.6% | +6.5% | -32.6% | -1.9% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.